Dimensional Fund Advisors LP Sage Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 874,166 shares of SAGE stock, worth $7.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

874,166

Previous 481,777 81.45%

Holding current value

$7.59 Million

Previous $3.83 Million 108.15%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.38 - $9.3 $2.5 Million - $3.65 Million	392,389 Added 81.45%	874,166 $7.97 Million
Q1 2025 May 13, 2025	SELL	$5.55 - $8.66 $19,857 - $30,985	-3,578 Reduced 0.74%	481,777 $3.83 Million
Q4 2024 Feb 13, 2025	SELL	$4.78 - $8.57 $19,019 - $34,100	-3,979 Reduced 0.81%	485,355 $2.64 Million
Q3 2024 Nov 07, 2024	SELL	$7.02 - $13.08 $140,596 - $261,966	-20,028 Reduced 3.93%	489,334 $3.53 Million
Q2 2024 Aug 09, 2024	SELL	$10.58 - $17.9 $4.4 Million - $7.45 Million	-416,216 Reduced 44.97%	509,362 $5.53 Million
Q1 2024 May 10, 2024	SELL	$18.62 - $26.95 $784,032 - $1.13 Million	-42,107 Reduced 4.35%	925,578 $17.3 Million
Q4 2023 Feb 07, 2024	SELL	$17.1 - $22.26 $6.15 Million - $8.01 Million	-359,906 Reduced 27.11%	967,685 $21 Million
Q3 2023 Nov 09, 2023	SELL	$16.75 - $48.98 $6.51 Million - $19 Million	-388,677 Reduced 22.65%	1,327,591 $27.3 Million
Q2 2023 Aug 09, 2023	BUY	$40.65 - $59.54 $2.5 Million - $3.67 Million	61,568 Added 3.72%	1,716,268 $80.7 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $12.5 Million - $15.6 Million	335,966 Added 25.48%	1,654,700 $69.4 Million
Q4 2022 Feb 09, 2023	BUY	$32.2 - $43.61 $7.82 Million - $10.6 Million	242,969 Added 22.59%	1,318,734 $50.3 Million
Q3 2022 Nov 10, 2022	BUY	$32.28 - $43.27 $13.7 Million - $18.3 Million	422,868 Added 64.77%	1,075,765 $42.1 Million
Q2 2022 Aug 12, 2022	BUY	$27.52 - $37.99 $13.3 Million - $18.3 Million	481,867 Added 281.74%	652,897 $21.1 Million
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $419,345 - $624,170	-13,655 Reduced 7.39%	171,030 $5.66 Million
Q4 2021 Feb 09, 2022	SELL	$37.06 - $47.11 $747,907 - $950,726	-20,181 Reduced 9.85%	184,685 $7.86 Million
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $6.74 Million - $9.61 Million	-167,445 Reduced 44.97%	204,866 $9.08 Million
Q2 2021 Aug 12, 2021	BUY	$54.88 - $79.29 $11.6 Million - $16.8 Million	211,539 Added 131.58%	372,311 $21.2 Million
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $2.33 Million - $3.19 Million	-32,990 Reduced 17.03%	160,772 $12 Million
Q4 2020 Feb 25, 2021	BUY	$58.41 - $89.06 $11.3 Million - $17.3 Million	193,762 New	193,762 $16.8 Million

Others Institutions Holding SAGE

# of Institutions

219

Shares Held

50.2M

Call Options Held

790K

Put Options Held

440K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Sage Therapeutics, Inc. Transaction History